Microdosing mushrooms.
Every question answered.
In 90 seconds.

Community ranges for dried Psilocybe cubensis run roughly 0.1–0.3 g; potency varies by strain and batch, so a lab-tested product matters. iMicrodosing’s program starts every client at 0.15 g and adjusts from a free assessment. Dose levels →

Check the law in your state, check your medications for interactions, pick a documented product and a schedule (Fadiman: one day on, two off; Stamets: four on, three off), then track how you feel. Getting-started checklist →

iMicrodosing has nine community locations (Denver, Lancaster, Los Angeles, New York, Phoenix, San Diego, Scottsdale, Spokane, Tampa), by appointment, and ships lab-verified products free in the U.S. Locations near me →

A small amount intended to remain below obvious psychedelic effects. Commonly discussed amounts and schedules vary, and controlled research has not established one universal dose, rhythm, or response timeline.

No. Commonly discussed ranges are descriptive. Mushroom potency and individual sensitivity vary, so a weight cannot function as a universal instruction.

Some observational studies and self-reports describe changes in anxiety or reactivity, while controlled microdosing evidence remains mixed and expectation effects are important. Full anxiety page →

A community framework commonly described as one use day followed by two non-use days. Controlled research has not established it as universally superior or defined a required cycle length. Full getting started guide →

Psilocybin remains Schedule I federally. Oregon and Colorado have distinct regulated frameworks, and some cities use local enforcement-priority policies. These are not nationwide legalization or ordinary retail access.

Formats differ in measurement, ingredient clarity, convenience, and batch consistency. No evidence establishes one format as universally better or clinically more effective. Full comparison →